Online Intervention for Cancer Patients

Not Applicable

Completed

• Conditions: Cancer

• Registration Number: NCT06745674
• Lead Sponsor: The Hong Kong Polytechnic University

Brief Summary

This study will focus on supporting cancer patients who often experience emotional challenges like anxiety and depression. It will test a two-week online program called Acceptance and Commitment Therapy (ACT), designed to help people manage difficult emotions and focus on what matters most in their lives.

The program will include short, easy-to-follow sessions covering helpful strategies like accepting distress and staying present in the moment. Participants will be randomly assigned to either join the ACT program or wait for the program while continuing their usual care. The study aims to determine whether the ACT program can reduce psychological distress, anxiety, and depression in cancer patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-01
• Primary Completion: 2023-06-01
• Study Completion: 2023-06-01
• Status Verified: 2024-12
• Study First Submitted: 2024-12-08
• Study First Submitted QC: 2024-12-17
• Last Update Submitted: 2024-12-17
• Study First Posted: 2024-12-20
• Last Update Posted: 2024-12-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• age 18 and above;
• diagnosed cancer with a clear disease course
• fluent in Chinese with the ability to read and understand questionnaires independently;
• ability to operate a smartphone independently;
• not participating in or intervening in other clinical studies.

Read More

Exclusion Criteria

• younger than 18 years of age
• unable to use a smartphone
• have significant cognitive impairment or a serious systemic disease or psychiatric disorder
• concurrently participating in other clinical studies or undergoing other psychotherapy

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Feasibility outcomes	Post-intervention (immediately after the 2-week intervention)	Feasibility is evaluated using three primary indicators: recruitment rate, retention rate, and intervention completion rate. Recruitment rate refers to the proportion of eligible participants who agreed to participate and completed the baseline assessments. Retention rate reflects the percentage of participants who successfully completed all study-related measurements throughout the trial.
Psychological Distress	Baseline, one week post-baseline, and post-intervention (immediately after the 2-week intervention)	Psychological distress is assessed using the Distress Thermometer (DT) (Holland et al., 2013). Scores range from 0 (no distress) to 10 (extreme distress), with higher scores reflecting greater levels of psychological distress.
Anxiety and Depression	Baseline, one week post-baseline, and post-intervention (immediately after the 2-week intervention)	Anxiety and depression are measured using the Hospital Anxiety and Depression Scale (HADS) (Zigmond \& Snaith, 1983), a 14-item questionnaire comprising separate subscales for anxiety and depression. Each item is scored on a 4-point Likert scale, and higher scores reflect greater severity of anxiety and depression symptoms.
Acceptability	Post-intervention (immediately after the 2-week intervention)	Acceptability is evaluated using the Client Satisfaction Questionnaire (CSQ-8) (Larsen et al., 1979). This 8-item measure uses a 4-point Likert scale (1 = low satisfaction to 4 = high satisfaction), with higher scores indicating greater satisfaction with the treatment.

Trial Locations

Locations (1)

Hubei Cancer Hospital; 🇨🇳 Wuhan, Hubei, China